These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21205250)

  • 1. Feasibility and safety of intravenous thrombolysis for acute ischaemic stroke in northern Greece.
    Rudolf J; Tsivgoulis G; Deretzi G; Heliopoulos I; Vadikolias K; Tsiptsios I; Piperidou C
    Int J Stroke; 2011 Feb; 6(1):91-2. PubMed ID: 21205250
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.
    Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N;
    Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Herzig R; Zapletalová J; Horák D; Král M; Skoloudík D; Bártková A; Veverka T; Heřman M; Kaňovský P
    Acta Neurol Scand; 2011 May; 123(5):339-44. PubMed ID: 20597864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience.
    Uyttenboogaart M; Schrijvers EM; Vroomen PC; De Keyser J; Luijckx GJ
    Age Ageing; 2007 Sep; 36(5):577-9. PubMed ID: 17405776
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
    de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E
    Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated.
    Kobayashi A; Skowronska M; Litwin T; Czlonkowska A
    Emerg Med J; 2007 Feb; 24(2):96-9. PubMed ID: 17251612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should more patients with acute ischaemic stroke receive thrombolytic treatment?
    Wardlaw JM; Sandercock PA; Murray V
    BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
    Wahlgren NG
    Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 17. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
    Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolytic therapy for acute ischemic stroke.
    Wechsler LR
    N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombolytic therapy with alteplase for ischaemic stroke.
    Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous thrombolysis in the treatment of acute ischaemic stroke: 3, 4.5, or 6 hours?].
    Kwieciński H
    Neurol Neurochir Pol; 2009; 43(3):213-5. PubMed ID: 19618303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.